BridgeBio has significantly improved this progress of the new therapy for amyloid heart disease, utilizing Attruby. Initial clinical data reveals potential benefits for individuals diagnosed by this debilitating https://biotech990545.snack-blog.com/42359169/company-advances-cardiac-amyloidosis-management-using-the-drug